Zobrazeno 1 - 10
of 63
pro vyhledávání: '"L. N. SERNOV"'
Autor:
K. V. SAROYAN, I. N. SYTNIK, V. O. SOLDATOV, M. A. PERSHINA, N. I. ZHERNAKOVA, S. V. POVETKIN, L. N. SERNOV
Publikováno v:
Кубанский научный медицинский вестник, Vol 25, Iss 4, Pp 124-131 (2018)
The problem of radiation-induced lesions is becoming increasingly urgent. Studies in recent years show that one of the most vulnerable tissues is the endothelium when exposed to high doses of ionizing radiation. The study of the pathogenetic bases of
Externí odkaz:
https://doaj.org/article/73a15e6b61b94f908d389b131101eb2e
Publikováno v:
Кубанский научный медицинский вестник, Vol 0, Iss 3, Pp 100-105 (2017)
Aim. To study the cardioprotective effects of exenatide and vildagliptin on the doxorubicin model of cardiomyopathy.Material and methods. In the experiments at the isolated the Langendorff heart of the rat, the cardioprotective effect of exenatide (1
Externí odkaz:
https://doaj.org/article/3750269ea77347df9c91b6811b8fd8f7
Autor:
A. N. TISHIN, M. V. POKROVSKII, O. M. TISHINA, L. N. SERNOV, V. J. PROVOTOROV, E. A. BESKHMELNITSYNA
Publikováno v:
Кубанский научный медицинский вестник, Vol 0, Iss 3, Pp 106-113 (2017)
Aim. To study the sorption activity of enterosorbent based on montmorillonite under the laboratory cipher of Crim_04 against E.coli enterotoxin in vivo.Material and Methods. Isolated loops of the small intestine were formed in laboratory rats under a
Externí odkaz:
https://doaj.org/article/a19b0cddbb794051b3dd5f3c1f8fdb6b
Autor:
T. A. Denisyuk, M. V. Pokrovsky, G. A. Lazareva, T. G. Pokrovskaya, M. V. Korokin, O. A. Osipova, A. I. Lazarev, L. N. Sernov, S. A. Demchenko
Publikováno v:
Кубанский научный медицинский вестник, Iss 1, Pp 30-34 (2016)
Using of the combined use of non-selective inhibitor of arginase L-norvaline with simvastatin, atorvastatin, rosuvastatin and rosuvastatin nanopartikulirovanny on background modeling endotoxin-induced disease, the introduction of strain 603 Staphyloc
Externí odkaz:
https://doaj.org/article/a0349a37d2be434a88ebed974ee9d8c4
Autor:
A. A. Kotljarov, L. N. Sernov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 77-82 (2003)
The aim of the study was to assess the influence of intravenous administration of mexicor (7mg / kg) on electrophysiological, hemodynamic action and antiarrhythmic activity of nibentan (1 mg / kg), propranolol (1,4mg / kg) and verapamil (0,4mg / kg)
Externí odkaz:
https://doaj.org/article/8dc8fc8fa74642f9a5351aaf05754716
Autor:
V. A. Evteev, L. N. Sernov, N. D. Bunyatyan, M. Samiev, G. M. Bobizoda, O. A. Popova, A. B. Prokof’ev
Publikováno v:
Pharmaceutical Chemistry Journal. 54:914-917
Tripeptide H-Lys-Lys-Gly-OH was synthesized. Its toxic properties and biological activity were studied. The tripeptide was synthesized by extending the peptide chain from the C-terminus by synthesizing N2, N6-dicarbobenzoxylysine [N2,N6-(Cbz)2Lys] an
Publikováno v:
I.P.Pavlov Russian Medical Biological Herald. 25:551-564
Aim. To study the antidiarrheal activity of enterosorbent on the basis of montmorillonite on the model of serotonin-induced diarrhea. Materials and Methods. The study was conducted on laboratory mice of both sexes, acute diarrhea was induced by intra
Autor:
N. V. Avdeeva, S. A. Sidorova, L. N. Sernov, S. V. Povetkin, 'Pharmoconsulting' Llc, N. I. Zhernakova
Publikováno v:
University proceedings. Volga region. Medical sciences.
Publikováno v:
Pharmaceutical Chemistry Journal. 46:199-202
The new 3-hydroxypyridine derivative 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyl-L-glutamate (EMOP-AG) was synthesized. It was established that EMOP-AG (10 and 30 mg/kg, single administration) exhibited antihypoxic activity on various models of acu
Autor:
V. P. Balashov, D S Blinov, T. V. Krasilina, L. N. Sernov, L. V. Van’kova, G. G. Boiko, Gogina Ed, E V Blinova, M. V. Vertyankin, L. V. Pivkina
Publikováno v:
Bulletin of Experimental Biology and Medicine. 152:583-586
Experiments on rats with myocardium infarction showed that intravenous administration of etoxidol in a dose of 14.2 mg/kg restricted the size of necrosis area and reduced the ratio of necrosis/ischemia zones. The test compound reduced the risk of rhy